Current Events / Press

"October 7, 2009 - Vector Production almost completed."

Vector production is almost finished we will begin Clinical Trials on the first patients in the first quarter of 2010.

Keep your prayers coming....

Thanks to all -

Pat Girondi

 

 

Read the latest article about Pat from The Chicago Family Health Examiner-

Click here:

http://www.examiner.com/examiner/x-7158-Chicago-Family-Health-Examiner~y2009m8d4-A-family-health-story--A-dads-fight-to-keep-his-son-alive

 

 

"July 13, 2009 - Vector production begins!"

As we speak, vector is being made for the first patients. We believe that the vector will be finished and tested by October-November. At that time, the treating doctors will make the decision on when to commence.

Thanks to all of you.

Pat Girondi

 

"April 29, 2008 - A successful pre-IND meeting with the FDA!"

The IND is being written as we speak. It's completion goal is for year's end. Vector will then be ordered and the first patients dosed in the second quarter of 2009.

Keep the prayers coming. .

Thanks to all of you.

Pat Girondi

 

 

“April 2007 - Thalagen RAC protocol submitted!”

The RAC is a panel of up to 21 national experts in various fields various fields of science, medicine, genetics, ethics, and patient perspectives that considers the current state of knowledge and technology regarding recombinant DNA research. A key role of the RAC is to advise the NIH Director and the NIH Office of Biotechnology Activities (OBA), which is the NIH locus of oversight for recombinant DNA research. In this capacity, the RAC recommends changes to the NIH Guidelines for Research Involving Recombinant DNA Molecules (NIH Guidelines), which outline responsible research practices in basic and clinical recombinant DNA research.

Another important RAC function is to review research proposals involving human gene transfer research, or "gene therapy" as it is often called. All human gene transfer trials occurring at or sponsored by institutions receiving NIH funds for recombinant DNA research must be submitted to OBA for review by the RAC.

 

"One Man's Story" Click here for translated article.

Translated by Lara Musard

The article was originally written by Onofrio Pepe in the 'Corriere della Sera' a national Italian paper. Click here for original article in Italian

Chicago Sun-Times:

"Biotech Entrepreneur Girondi Seeks Orphan Disease, Son's Cure"

Monday, August 28th, 2006 ( PDF )

University of Notre Dame College of Science Article ( PDF )

Coming Soon:
-Orphan's Hope Released in April 2009
- Focaccia Blues Release in October 2008
- "Paradise On Earth" - a PBS Documentary on the life story of Pat Girondi.